What is the treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

Topical antibiotics are recommended for bacterial conjunctivitis as they reduce symptom duration and improve clinical outcomes, even in mild cases. 1

Treatment Based on Severity

Mild to Moderate Bacterial Conjunctivitis

  • A 5-7 day course of broad-spectrum topical antibiotic is recommended as it accelerates clinical and microbiological remission, reduces transmissibility, and allows earlier return to school/work 1
  • Fluoroquinolones (e.g., gatifloxacin, moxifloxacin) are effective against common pathogens including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Haemophilus influenzae 2
  • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics and can be considered when access to antibiotics is limited 3
  • Patients should be advised to return for follow-up if no improvement is seen after 3-4 days of treatment 3

Moderate to Severe Bacterial Conjunctivitis

  • Characterized by copious purulent discharge, pain, and marked inflammation 3
  • Obtain conjunctival cultures and Gram staining before initiating treatment, especially if gonococcal infection is suspected 3, 1
  • Choice of antibiotic should be guided by laboratory test results 3
  • Consider methicillin-resistant S. aureus (MRSA) as a potential pathogen, which may require specialized antibiotics such as vancomycin 3

Special Cases

Gonococcal Conjunctivitis

  • Requires systemic antibiotic therapy rather than topical treatment alone 3, 1
  • Saline lavage may promote comfort and more rapid resolution of inflammation 3
  • If corneal involvement is present, add topical treatment as for bacterial keratitis 3
  • Patients should be seen daily until resolution 3
  • Screen for concomitant sexually transmitted infections and treat sexual contacts 3, 1

Chlamydial Conjunctivitis

  • Requires systemic antibiotic therapy, especially in infants who may have infection at other sites 3, 1
  • No evidence supports additional topical therapy beyond systemic treatment 1
  • For neonates with chlamydial conjunctivitis, oral erythromycin is recommended 1
  • Treatment failure can occur in up to 19% of cases, requiring re-evaluation 3
  • Sexual contacts should be treated concurrently 3

Antibiotic Selection

  • Gatifloxacin 0.5% ophthalmic solution: Instill one drop every two hours while awake (up to 8 times) on Day 1, then 2-4 times daily on Days 2-7 2
  • Effective against common pathogens including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Haemophilus influenzae 2
  • Other effective options include ciprofloxacin, chloramphenicol, and rifampin 4
  • Besifloxacin 0.6% ophthalmic suspension has shown high potency against common ocular pathogens, including bacteria resistant to other fluoroquinolones 5

Pitfalls and Caveats

  • Bacterial resistance is a growing concern, particularly with MRSA infections 3, 6
  • Poor adherence to frequent administration regimens can contribute to treatment failure 1
  • Contact lens wear should be discontinued during treatment 2
  • Consider sexual abuse in children with gonococcal or chlamydial conjunctivitis 3, 1
  • Most cases of bacterial conjunctivitis are self-limiting, but treatment shortens duration and reduces contagion 7
  • Increasing resistance to fluoroquinolones has been reported, particularly in Staphylococcal species 6
  • Methicillin-resistant S. aureus may require specialized antibiotics as they are often resistant to commercially available topical antibiotics 3

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Bacterial conjunctivitis: most prevalent pathogens and their antibiotic sensitivity].

Anales de pediatria (Barcelona, Spain : 2003), 2004

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.